a distributer of pharmaceuticals and provides healthcare software and health information technology services
Industry MedicalDistributors
Loading...
McKesson (MCK, $1,072) was one of top quarterly gainers, jumping +2 to $1,072 per share. A.I.dvisor analyzed 11 stocks in the Medical Distributors Industry over the last three months, and discovered that of them () charted an Uptrend while of them () trended down.
MCK's Aroon Indicator triggered a bullish signal on November 12, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 355 similar instances where the Aroon Indicator showed a similar pattern. In 260 of the 355 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 73%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on MCK as a result. In 54 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for MCK just turned positive on November 04, 2026. Looking at past instances where MCK's MACD turned positive, the stock continued to rise in 33 of 52 cases over the following month. The odds of a continued upward trend are 63%.
Following a +7.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCK advanced for three days, in 254 of 382 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
MCK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 7 (best 1 - 100 worst), indicating outstanding price growth. MCK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-29.171) is normal, around the industry mean (14.423). MCK has a moderately high P/E Ratio (28.334) as compared to the industry average of (11.188). Projected Growth (PEG Ratio) (1.616) is also within normal values, averaging (2.016). Dividend Yield (0.004) settles around the average of (0.134) among similar stocks. P/S Ratio (0.265) is also within normal values, averaging (4.260).
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.